Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Placebo
SUPERNUS PHARMACEUTICALS, INC.
ADHD
5 trials -
Placebo
Amphastar France Pharmaceuticals
Asthma
1 trial -
Placebo
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis, Homozygous for the F508del CFTR Mutation
1 trial -
Placebo
IRONWOOD PHARMACEUTICALS INC
Irritable Bowel Syndrome With Constipation (IBS-C)
1 trial -
Placebo
Hoffmann-La Roche
Schizophrenia
1 trial -
Placebo
Biogen
Multiple Sclerosis, Remittent Progressive
1 trial -
Placebo
Regeneron UK Limited
Colorectal Neoplasms
1 trial -
Placebo
Agios Netherlands B.V.
Pyruvate Kinase Deficiency
1 trial -
Placebo
SUPERNUS PHARMACEUTICALS, INC.
Attention-Deficit/Hyperactivity Disorder (ADHD)
2 trials -
Placebo
Takeda
Hypoparathyroidism
1 trial -
Placebo
Pacira Ireland Limited
Postoperative Pain
1 trial -
Placebo
United Therapeutics Europe Ltd
Idiopathic Pulmonary Fibrosis
1 trial -
Placebo
Takeda
Lennox Gastaut Syndrome (LGS)
1 trial -
Placebo
Takeda
Hypertension
1 trial -
Placebo
Madrigal Pharmaceuticals EU Limited
Non-Alcoholic Fatty Liver Disease
1 trial -
Placebo
Amneal Pharma Europe Ltd
Asthma
1 trial -
Placebo
Takeda
Diabetes
1 trial -
Placebo
Takeda
Attention Deficit Hyperactivity Disorder (ADHD)
1 trial -
Placebo
LEXICON PHARMACEUTICALS, INC.
Type 2 Diabetes Mellitus
2 trials -
Placebo
Takeda
Healthy Volunteers
2 trials -
Placebo
Ark Therapeutics
Hyperphagia
1 trial -
Placebo
Kalvista Pharmaceuticals (Ireland) Limited
Hereditary Angioedema
1 trial -
Placebo
Pfizer
Ulcerative Colitis
1 trial -
Placebo
Takeda
Generalized Anxiety Disorder
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources